Jack Kramarczyk is an accomplished professional in the biotechnology sector with extensive experience in process development and engineering. Currently serving as Director at Moderna Therapeutics since July 2017, Kramarczyk leads a team focused on the encapsulation of mRNA into lipid nanoparticles and the associated downstream processing. Previously, at Axcella Health, Kramarczyk founded a laboratory and developed purification processes while managing a team of engineers. Kramarczyk has also worked as a Senior Process Engineer at Virdante Pharmaceuticals and Wyeth Biotech, where responsibilities included developing and supporting purification processes for therapeutic proteins. Kramarczyk holds a Master of Science in Chemical & Biotechnology Engineering and a Bachelor of Science in Chemical Engineering from Tufts University.
This person is not in any teams
This person is not in any offices